Lyell Immunopharma (LYEL) News Today → War Over Taiwan? Protect Your Wealth NOW (From Behind the Markets) (Ad) Free LYEL Stock Alerts $2.12 -0.08 (-3.64%) (As of 11:34 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLyell Immunopharma (NASDAQ:LYEL) Trading Up 5.8%marketbeat.com - April 22 at 4:46 PMLyell Immunopharma (NASDAQ:LYEL) Stock Price Down 4.6%americanbankingnews.com - April 20 at 6:14 AMLyell Immunopharma (NASDAQ:LYEL) Trading Down 4.6%marketbeat.com - April 18 at 1:56 PMLyell Immunopharma Inc Ordinary Shares LYELmorningstar.com - April 16 at 2:33 PMLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $3.01marketbeat.com - April 15 at 12:53 PMArgan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Fridaybenzinga.com - April 12 at 11:17 AMLyell Immunopharma (NASDAQ:LYEL) Trading Up 4.9%marketbeat.com - April 11 at 3:20 PMLyell Immunopharma (NASDAQ:LYEL) Stock Price Down 7.5%marketbeat.com - April 10 at 2:52 PMLyell Immunopharma (NASDAQ:LYEL) Trading 4.9% Higher marketbeat.com - April 4 at 2:24 PMOutpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meetingfinance.yahoo.com - April 4 at 8:15 AMBiomea Fusion drops as JPMorgan downgrades on data for lead assetseekingalpha.com - April 2 at 3:05 PMLyell Immunopharma (NASDAQ:LYEL) Trading Up 5.9%marketbeat.com - March 28 at 5:38 PM2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directorsfinance.yahoo.com - March 20 at 5:13 PMLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $1.99marketbeat.com - March 20 at 11:56 AMLyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returnsfinance.yahoo.com - March 17 at 5:25 PMLyell Immunopharma (NASDAQ:LYEL) Shares Gap Up to $2.18marketbeat.com - March 13 at 12:55 PMLyell Immunopharma (NASDAQ:LYEL) Shares Down 6.4% marketbeat.com - March 11 at 4:17 PMLyell Immunopharma, Inc: Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meetingfinanznachrichten.de - March 10 at 10:09 AMLyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meetingglobenewswire.com - March 5 at 4:30 PMLyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlightsfinance.yahoo.com - February 28 at 7:41 PMLyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023globenewswire.com - February 28 at 4:05 PMLyell Immunopharma Announces Participation in March Investor Conferencesglobenewswire.com - February 26 at 4:05 PMLyell Immunopharma Inc (LYEL)investing.com - February 20 at 8:22 PMLyell Immunopharma Stock (NASDAQ:LYEL) Dividends: History, Yield and Datesbenzinga.com - January 30 at 1:29 PMLyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 3 at 8:43 PMHeather D. Lyellhealth.usnews.com - December 19 at 2:11 PMCompanies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growthfinance.yahoo.com - December 19 at 9:11 AMLyell Immunopharma: Potential Solid Tumor Targeting With CAR-T And TILseekingalpha.com - November 10 at 4:53 PMWhy Lyell Immunopharma Shares Are Rising Todaymarkets.businessinsider.com - November 10 at 11:52 AMLyell gets FDA orphan drug designation for melanoma drug candidatemsn.com - November 9 at 10:43 PMLyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanomafinance.yahoo.com - November 9 at 5:42 PMLyell Immunopharma reports Q3 resultsmsn.com - November 8 at 9:01 PMLyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023finance.yahoo.com - November 7 at 5:45 PMLyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL Manufacturingfinance.yahoo.com - October 31 at 9:55 AMLyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 49% stakefinance.yahoo.com - October 9 at 7:56 AMLyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meetingfinance.yahoo.com - September 27 at 3:04 PMLyell Immunopharma Shares Up 8% on Cellares Collaborationmarketwatch.com - September 11 at 3:22 PMCellares and Lyell to Evaluate Automated Manufacturing of Lyell's CAR T-Cell Therapy on Cellares' Cell Shuttle Platformfinance.yahoo.com - September 11 at 10:02 AMXTX Topco Ltd Has $676,000 Stake in Lyell Immunopharma, Inc. (NASDAQ:LYEL)marketbeat.com - September 10 at 4:14 AMLyell Immunopharma to Participate in Upcoming Investor Conferencesfinance.yahoo.com - August 31 at 7:26 PMAnalysts' Revenue Estimates For Lyell Immunopharma, Inc. (NASDAQ:LYEL) Are Surging Higherfinance.yahoo.com - August 29 at 7:56 AMJP Morgan cuts Lyell to neutral, pending data for cell therapy platformmsn.com - August 28 at 9:48 PMJP Morgan Downgrades Lyell Immunopharma (LYEL)msn.com - August 28 at 4:48 PMBarclays PLC Has $579,000 Stock Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)marketbeat.com - August 27 at 4:03 AMLyell Immunopharma: Once Huge IPO Now Waiting For Clinical Datamsn.com - August 26 at 6:29 PMMirae Asset Global Investments Co. Ltd. Reduces Stock Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)marketbeat.com - August 24 at 4:01 AMH.C. Wainwright Reaffirms Their Buy Rating on Lyell Immunopharma (LYEL)markets.businessinsider.com - August 9 at 8:38 PMLyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023finance.yahoo.com - August 8 at 7:37 PMMaxCyte inks strategic platform license with Lyell Immunopharmalse.co.uk - July 6 at 1:19 PMMaxCyte Signs Strategic Platform License with Lyell Immunopharmafinance.yahoo.com - July 6 at 8:18 AM Get Lyell Immunopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter. Email Address War Over Taiwan? Protect Your Wealth NOW (Ad)With tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared. Access my report now >>> LYEL Media Mentions By Week LYEL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LYEL News Sentiment▼0.000.33▲Average Medical News Sentiment LYEL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LYEL Articles This Week▼21▲LYEL Articles Average Week Get Lyell Immunopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NUVB News ATXS News OLMA News MLYS News VERV News CVAC News ZYME News ALLO News SIGA News SLN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LYEL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
